Non-statin users also had lower body mass indexes and waist circumferences and a lower proportion of cardiovascular comorbidities, including hypertension, chronic kidney disease, cardiovascular disease, prolonged diabetes mellitus, and the use of insulin or multiple oral hypoglycemic agents. This evidence concerns the gene INS and diabetes mellitus.